Genetic sub-types of human malignant astrocytoma correlate with survival

International Journal of Cancer

Volumn 79, Issue 2, 1998, Pages 159-165

  Leenstra, Sieger ^a   Oskam, Niels T ^a   Bijleveld, Engelien H ^a   Bosch, D Andries ^a   Troost, Dirk ^a   Hulsebos, Theo J M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ARTICLE; ASTROCYTOMA; CANCER GRADING; CANCER SURVIVAL; CHROMOSOME 10; GENE AMPLIFICATION; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; MUTATION; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; ASTROCYTOMA; BRAIN NEOPLASMS; CHROMOSOME DELETION; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 10; FEMALE; GENES, P53; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; MUTATION; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SURVIVAL RATE; TIME FACTORS;

EID: 0031920406     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980417)79:2<159::AID-IJC11>3.0.CO;2-5     Document Type: Article

References (21)

1. BURGER, P.C. and GREEN, S.B., Patient age, histologic features, and length of survival in patients with glioblastoma multiforme. Cancer, 59, 1617- 1625 (1987).
2. BURGER, P.C. and VOGEL, F.S., Glioblastoma multiforme and anaplastic astrocytoma. Pathologic criteria and prognostic implications. Cancer, 56, 1106-1111 (1985).
3. CAMPOMENOSI, P. and 18 OTHERS, Study on aneuploidy and p53 mutations in astrocytomas. Cancer Genet. Cytogenet., 88, 95-102 (1996).
4. CHOZICK, B.S., PEZZULLO, J.C., EPSTEIN, M.H. and FINCH, P.W., Prognostic implications of p53 over-expression in supratentorial astrocytic tumors. Neurosurgery, 35, 831-837 (1994).
5. HUNTER, S.B., ABBOTT, K., VARMA, V.A., OLSON, J.J., BARNETT, D.W. and JAMES, C.D., Reliability of differential PCR for the detection of EGFR- and MDM2-gene amplification in DNA extracted from FFPE gliomu tissue. J. Neuropathol. Neurol., 54, 57-64 (1995).
6. IWADATE, Y., FUJIMOTO, S., TAGAWA, M., NAMBA, H., SUEYOSHI, K., HIROSE, M. and SAKIYAMA, S., Association of p53-gene mutation with decreased chemosensitivity in human malignant gliomas. Int. J. Cancer, 69, 236-240 (1996).
7. KIMMELMAN, A.C., ROSS, D.A. and LIANG, B.C., Loss of heterozygosity of chromosome 10p in human gliomas. Genomics, 34, 250-254 (1996).
8. KLEIHUES, P., BURGER, P. and SCHEITHAUER, B., Histological typing of tumours of the central nervous system. World Health Organization, 2nd ed., Springer, Berlin, Heidelberg, New York (1993).
9. KYRITSIS, A.P., BONDY, M.L., HESS, K.R., CUNNINGHAM, J.E., ZHU, D., AMOS, C.J., YUNG, W.K.A., LEVIN, V.A. and BRUNER, J.M., Prognostic significance of p53 immunoreactivity in patients with glioma. Clin. Cancer Res., 1, 1617-1622 (1995).
10. LANG, F.F., MILLER, D.C., KOSLOW, M. and NEWCOMB, E.W., Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors. J. Neurosurg., 81, 427-436 (1994).
11. LEENSTRA, S., BIJLSMA, E.K., TROOST, D., OOSTING, J., WESTERVELD, A., BOSCH, D.A. and HULSEBOS, T.J.M., Allele loss on chromosomes 10 and 17p and epidermal-growth-factor-receptor-gene amplification in human malignant astrocytoma related to prognosis. Brit. J. Cancer, 70, 684-689 (1994).
12. LI, J. and 16 OTHERS, PTEN, a putative protein-tyrosine-phosphatase gene mutated in human brain, breast and prostate cancer. Science, 275, 1943- 1947 (1997).
13. LI, Y.J., SANSON, M., HOANGXUAN, K., DELATTRE, J.Y., POISSON, M., THOMAS, G. and HAMELIN, R., Incidence of germ-line p53 mutations in patients with gliomas. Int. J. Cancer, 64, 383-387 (1995).
14. MOLLENHAUER, J., WIEMANN, S., SCHEURLEN, W., KORN, B., HAYASHI, Y., WILGENBUS, K.K., VON DEIMLING, A. and POUSTKA, A., DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3-26.1, is deleted in malignant brain tumours. Nature Genet., 17, 32-39 (1997).
15. RASHEED, B.K., MCLENDON, R.E., HERNDON, J.E., FRIEDMAN, H.S., FRIEDMAN, A.H., BIGNER, D.D. and BIGNER, S.H., Alterations of the TP53 gene in human gliomas. Cancer Res., 54, 1324-1330 (1994).
16. STECK, P.A. and 16 OTHERS, Identification of a candidate tumour-suppressor gene. MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nature Genet., 15, 356-362 (1997).
17. VOESTEN, A.M.J., BIJLEVELD, E.H., WESTERVELD, A. and HULSEBOS, T.J.M., Fine mapping of a region of common deletion on chromosome arm 10p in glioma. Genes Chrom. Cancer, 20, 167-172 (1997).
18. VON DEIMLING, A., VON AMMON, K., SCHOENFELD, D., WIESTLER, O.D., SEIZINGER, B.R. and LOUIS, D.N., Sub-sets of glioblastoma multiforme defined by molecular genetic analysis. Brain Pathol., 3, 19-26 (1993).
19. WAHA, A., BAUMANN, A., WOLF, H.K., FIMMERS, R., NEUMANN, J., KINDERMANN, D., ASTRAHANTSEFF, K., BLUMCKE, I., VON DEIMLING, A. and SCHLEGEL, U., Lack of prognostic relevance of alterations in the epidermal- growth-factor-receptor-transforming-growth-factor-alpha pathway in human astrocytic gliomas. J. Neurosurg., 85, 634-641 (1996a).
20. WAHA, A., ROLLBROCKER, B., WIESTLER, O.D. and VON DEIMLING, A., A polymerase-chain-reaction-based assay for the rapid detection of gene amplification in human tumors. Diagn. mol. Pathol., 5, 147-150 (1996b).
21. WATANABE, K., TACHIBANA, O., SATO, K., YONEKAWA, Y., KLEIHUES, P. and OHGAKI, H., Over-expression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas. Brain Pathol., 6, 217-223 (1996).